These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8674335)

  • 21. Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
    Volman TJ; Goris RJ; Hendriks T
    Intensive Care Med; 2005 May; 31(5):701-8. PubMed ID: 15711975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice.
    Nieuwenhuijzen GA; Knapen MF; Hendriks T; van Rooijen N; Goris RJ
    Arch Surg; 1997 May; 132(5):533-9. PubMed ID: 9161398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmented enhancement of in vitro production of inflammatory cytokines in peripheral blood mononuclear cells in patients undergoing simultaneous resection of the liver and gastrointestinal tract.
    Sasada K; Miyazaki M; Nakagawa K; Ito H; Ambiru S; Shimizu H; Nakajima N
    Crit Care Med; 1999 May; 27(5):929-36. PubMed ID: 10362415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice.
    Ribeiro RA; Vale ML; Thomazzi SM; Paschoalato AB; Poole S; Ferreira SH; Cunha FQ
    Eur J Pharmacol; 2000 Jan; 387(1):111-8. PubMed ID: 10633169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan.
    Galuppo M; Nocentini G; Mazzon E; Ronchetti S; Esposito E; Riccardi L; Di Paola R; Bruscoli S; Riccardi C; Cuzzocrea S
    Shock; 2011 Sep; 36(3):263-71. PubMed ID: 21654556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.
    Li YM; Wang HB; Zheng JG; Bai XD; Zhao ZK; Li JY; Hu S
    World J Gastroenterol; 2015 Oct; 21(38):10853-65. PubMed ID: 26478676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties.
    Ku G; Doherty NS; Schmidt LF; Jackson RL; Dinerstein RJ
    FASEB J; 1990 Apr; 4(6):1645-53. PubMed ID: 2318380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation.
    Fan H; Wong D; Ashton SH; Borg KT; Halushka PV; Cook JA
    Inflammation; 2012 Feb; 35(1):130-7. PubMed ID: 21274742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome.
    Volman TJ; Hendriks T; Goris RJ
    Shock; 2005 Apr; 23(4):291-7. PubMed ID: 15803050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
    Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do diets enriched with oil prevent multiple organ failure in mice?
    Gielen CJ; van As AB; Goris RJ
    Eur J Surg; 1993; 159(11-12):609-12. PubMed ID: 8130302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model.
    von Asmuth EJ; Maessen JG; van der Linden CJ; Buurman WA
    Scand J Immunol; 1990 Oct; 32(4):313-9. PubMed ID: 2237286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
    Di Paola R; Galuppo M; Mazzon E; Paterniti I; Bramanti P; Cuzzocrea S
    Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
    Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
    Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages.
    Tripathi S; Maier KG; Bruch D; Kittur DS
    J Surg Res; 2007 Apr; 138(2):209-13. PubMed ID: 17291534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta.
    Netea MG; Kullberg BJ; Verschueren I; Van Der Meer JW
    Eur J Immunol; 2000 Oct; 30(10):3057-60. PubMed ID: 11069090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The different effects of glutamine on macrophage cytokines release in vivo and in vitro].
    Wang XM; Liang MF; Yuan Y; Jiang W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):456-60. PubMed ID: 18687170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome.
    Volman TJ; Hendriks T; Verhofstad AA; Kullberg BJ; Goris RJ
    Shock; 2002 Jun; 17(6):468-72. PubMed ID: 12069182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome.
    Reid CL; Perrey C; Pravica V; Hutchinson IV; Campbell IT
    Crit Care Med; 2002 Oct; 30(10):2216-21. PubMed ID: 12394947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2008 Nov; 8(11):1567-77. PubMed ID: 18656556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.